These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


434 related items for PubMed ID: 15698636

  • 1. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.
    Yu WF, Guan ZZ, Bogdanovic N, Nordberg A.
    Exp Neurol; 2005 Mar; 192(1):215-25. PubMed ID: 15698636
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
    Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E.
    Glia; 2003 Jan 15; 41(2):207-11. PubMed ID: 12509811
    [Abstract] [Full Text] [Related]

  • 3. Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
    Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK.
    J Neurol Sci; 2004 Oct 15; 225(1-2):39-49. PubMed ID: 15465084
    [Abstract] [Full Text] [Related]

  • 4. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42).
    Xiu J, Nordberg A, Zhang JT, Guan ZZ.
    Neurochem Int; 2005 Sep 15; 47(4):281-90. PubMed ID: 15955596
    [Abstract] [Full Text] [Related]

  • 5. The consequences of reducing expression of the alpha7 nicotinic receptor by RNA interference and of stimulating its activity with an alpha7 agonist in SH-SY5Y cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease.
    Qi XL, Nordberg A, Xiu J, Guan ZZ.
    Neurochem Int; 2007 Sep 15; 51(6-7):377-83. PubMed ID: 17493709
    [Abstract] [Full Text] [Related]

  • 6. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J, Fukumoto H, Orne J, Klucken J, Raju S, Vanderburg CR, Irizarry MC, Hyman BT, Ingelsson M.
    Exp Neurol; 2005 Jul 15; 194(1):91-6. PubMed ID: 15899246
    [Abstract] [Full Text] [Related]

  • 7. Amyloid precursor protein gene mutated at Swedish 670/671 sites in vitro induces changed expression of nicotinic acetylcholine receptors and neurotoxicity.
    An Y, Qi XL, Pei JJ, Tang Z, Xiao Y, Guan ZZ.
    Neurochem Int; 2010 Nov 15; 57(6):647-54. PubMed ID: 20696195
    [Abstract] [Full Text] [Related]

  • 8. Metallothionein-I and -III expression in animal models of Alzheimer disease.
    Carrasco J, Adlard P, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J.
    Neuroscience; 2006 Dec 28; 143(4):911-22. PubMed ID: 17027170
    [Abstract] [Full Text] [Related]

  • 9. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M, Hellström-Lindahl E.
    Neurochem Int; 2009 Dec 28; 54(3-4):237-44. PubMed ID: 19111588
    [Abstract] [Full Text] [Related]

  • 10. Inflammation occurs early during the Abeta deposition process in TgCRND8 mice.
    Dudal S, Krzywkowski P, Paquette J, Morissette C, Lacombe D, Tremblay P, Gervais F.
    Neurobiol Aging; 2004 Aug 28; 25(7):861-71. PubMed ID: 15212840
    [Abstract] [Full Text] [Related]

  • 11. Influence of cholesterol and lovastatin on alpha-form of secreted amyloid precursor protein and expression of alpha7 nicotinic receptor on astrocytes.
    Xiu J, Nordberg A, Qi X, Guan ZZ.
    Neurochem Int; 2006 Oct 28; 49(5):459-65. PubMed ID: 16675062
    [Abstract] [Full Text] [Related]

  • 12. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A.
    J Alzheimers Dis; 2011 Oct 28; 23(2):335-47. PubMed ID: 21116052
    [Abstract] [Full Text] [Related]

  • 13. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S, Counts SE, Ma SY, Dadko E, Gordon MN, Morgan D, Mufson EJ.
    Exp Neurol; 2001 Aug 28; 170(2):227-43. PubMed ID: 11476589
    [Abstract] [Full Text] [Related]

  • 14. Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques.
    Steinhoff T, Moritz E, Wollmer MA, Mohajeri MH, Kins S, Nitsch RM.
    Neurobiol Dis; 2001 Aug 28; 8(4):647-54. PubMed ID: 11493029
    [Abstract] [Full Text] [Related]

  • 15. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
    Schwab C, Hosokawa M, McGeer PL.
    Exp Neurol; 2004 Jul 28; 188(1):52-64. PubMed ID: 15191802
    [Abstract] [Full Text] [Related]

  • 16. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    Mohri I, Kadoyama K, Kanekiyo T, Sato Y, Kagitani-Shimono K, Saito Y, Suzuki K, Kudo T, Takeda M, Urade Y, Murayama S, Taniike M.
    J Neuropathol Exp Neurol; 2007 Jun 28; 66(6):469-80. PubMed ID: 17549007
    [Abstract] [Full Text] [Related]

  • 17. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR, Reiser PA, Gumula NA, Hertzog BM, Andrade-Gordon P.
    Biotech Histochem; 2001 Mar 28; 76(2):97-106. PubMed ID: 11440311
    [Abstract] [Full Text] [Related]

  • 18. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
    Ferrer I, Freixas M, Blanco R, Carmona M, Puig B.
    Neuropathol Appl Neurobiol; 2004 Aug 28; 30(4):329-37. PubMed ID: 15305978
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL.
    J Comp Neurol; 2003 Aug 04; 462(4):371-81. PubMed ID: 12811807
    [Abstract] [Full Text] [Related]

  • 20. Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: an immunohistochemical study.
    Teaktong T, Graham AJ, Johnson M, Court JA, Perry EK.
    Neuropathol Appl Neurobiol; 2004 Jun 04; 30(3):243-54. PubMed ID: 15175078
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.